HemaCare Gains OK on AIDS Drug Trials
- Share via
HemaCare Corp., a Sherman Oaks provider of blood products and related services, said it received approval from the state Department of Health Services to proceed with trials of a drug for treating patients with AIDS.
The drug, called Passive Hyperimmune Plasma, is meant to reduce infections in AIDS patients.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
